During the past decade, Toyohashi Municipal Hospital conducted 17 clinical trials. In the 10-year time frame, 17 clinical trials started and 10 clinical trials were completed, i.e. on average, 58.8% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 7 clinical trials were completed. i.e. 70% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Toyohashi Municipal Hospital" #1 sponsor was "Pfizer" with 6 trials, followed by "Amgen" with 4 trials sponsored, "Celgene" with 3 trials sponsored, "Arena Pharmaceuticals" with 2 trials sponsored and "BeiGene" with 2 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Toyohashi Municipal Hospital" #1 collaborator was "Arena is a wholly owned subsidiary of Pfizer" with 2 trials as a collaborator, "Japan Lung Cancer Society" with 1 trials as a collaborator, "Tokyo Medical and Dental University" with 1 trials as a collaborator and "Wyeth is now a wholly owned subsidiary of Pfizer" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Toyohashi Municipal Hospital" are "Multiple Myeloma" (6 trials), "Ulcerative Colitis" (4 trials), "Chronic Myeloid Leukemia" (2 trials), "Acute Myeloid Leukemia" (1 trials) and "Chronic Myelogenous Leukemia" (1 trials). Many other conditions were trialed in "Toyohashi Municipal Hospital" in a lesser frequency.

Most popular intervention types in "Toyohashi Municipal Hospital" are "Drug" (22 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Dexamethasone" (6 trials), "Carfilzomib" (5 trials), "Placebo" (5 trials), "Bortezomib" (4 trials) and "Daratumumab" (4 trials). Other intervention names were less common.

The vast majority of trials in "Toyohashi Municipal Hospital" are 24 trials for "All" genders.

Currently, there are NaN active trials in "Toyohashi Municipal Hospital". undefined are not yet recruiting, 5 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 15 completed trials in Toyohashi Municipal Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Toyohashi Municipal Hospital, 2 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 15 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".